Microbiological Profile and Antimicrobial Resistance Patterns of Pleural Fluid Isolates in a Tertiary Care Setting in

Hassan Imran1, Zaman Khan2, Fatima Iftikhar Shah1

  • 1University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, the University of Lahore, Lahore, Pakistan.

Insights

Bacterial pleural fluid infections are increasing due to antibiotic resistance. Colistin and vancomycin show effectiveness, but high Multiple Antibiotic Resistance (MAR) index indicates irrational drug use, necessitating better antibiotic stewardship.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Pleural fluid infections pose a significant clinical challenge, exacerbated by rising antibiotic resistance.
  • A substantial proportion of infections are caused by diverse bacterial pathogens, necessitating effective antimicrobial strategies.

Purpose of the Study:

  • To investigate the bacterial spectrum and antibiotic susceptibility patterns in pleural fluid infections.
  • To assess the prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria.
  • To analyze the Multiple Antibiotic Resistance (MAR) index and its correlation with patient factors.

Main Methods:

  • Analysis of 598 patient samples with pleural fluid infections.
  • Bacterial identification and antibiotic susceptibility testing.
  • Calculation of the Multiple Antibiotic Resistance (MAR) index and correlation analysis with gender, age, and Gram staining.

Main Results:

  • 15.88% of samples were culture-positive, identifying 18 bacterial species.
  • Colistin was effective against Gram-negative bacteria; vancomycin and linezolid against Gram-positive bacteria.
  • A high mean MAR index (0.543) indicated irrational antibiotic use; Gram staining showed a negative correlation with MAR index (p < 0.001).

Conclusions:

  • The study reveals a growing threat from multidrug-resistant and extensively drug-resistant bacteria in pleural infections.
  • Effective treatments are challenged by resistance patterns, especially in resource-limited settings.
  • Urgent need for enhanced antibiotic stewardship, public awareness, and continuous monitoring to combat antimicrobial resistance.